Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_assertion type Assertion NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_head.
- NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_assertion wasGeneratedBy ECO_0000203 NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_provenance.
- NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_assertion wasDerivedFrom befree-20140225 NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_provenance.
- NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_assertion SIO_000772 8100604 NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_provenance.
- NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_assertion evidence source_evidence_literature NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_provenance.
- NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_assertion description "[The expression of the multidrug resistance (MDR-1) gene product, P-170 glycoprotein (P-170) was investigated in 26 patients with low-risk (n = 9) or high-risk (n = 17) myelodysplastic syndrome (MDS), using a panel of monoclonal antibodies to P-170 (C219, JSB1, C494, MRK16) and quantitative analysis of MDR-1 mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562615.RAkeBQwLEPO4sWE-I5Cq6eOU4ReB9QjKakQRAsTVp6S0M130_provenance.